EUVIMEDEUVIMED entdecken
Crossref

Oral immunotherapy in alpha‐gal red meat allergy: Could specific IgE be a potential biomarker in monitoring management?

D Ünal iD, D Eyice-Karabacak iD, A Kutlu, S Demir iD, C Tüzer, A F Arslan, S R Işık, A Gelincik iD

Allergy · 2023-12 · 78 (12) · 3241-3251

DOI: 10.1111/all.15840 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, online erschienen am 07.08.2023. Verfasst von D Ünal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology and Allergy Diseases, Internal Medicine Department, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Tick Bites, Food Hypersensitivity, Red Meat. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oral immunotherapy (OIT) is a promising treatment for food allergies. Our aim was to establish the long‐term safety and efficacy of a novel red meat (RM) OIT in galactose‐alpha‐1,3‐galactose (alpha‐gal) allergy in adults.

Methods

Out of 20 patients with confirmed RM allergy, five (41.66%) underwent an early OIT, seven (58.33%) underwent a delayed protocol and eight patients who were not desensitized formed the patient control group. 15 and 27 day RM OIT for early‐onset and delayed‐onset alpha‐gal allergy were administered, respectively. Desensitized patients were recommended to continue eating at least 100 g RM every day for 6 months and every other day in the following 6 months. After a year, the consumption was recommended 2/3 times in a week. Patients were followed up with skin tests with commercial beef and lamb extracts, fresh raw/cooked beef and lamb and cetuximab and also with serum alpha‐gal specific Immunoglobulin‐E (sIgE) in the first and fifth years.

Results

All patients who underwent OIT became tolerant to RM. During the 5 year follow‐up, the median alpha‐gal sIgE concentration gradually decreased in nine patients who consumed RM uneventfully while remained unchanged in the control group ( p = .016). In two patients, rare tick bites acted as inducers of hypersensitivity reactions with concomitant elevation of alpha‐gal sIgE concentrations whereas one patient with low follow‐up alpha‐gal sIgE concentrations consumed RM uneventfully after frequent tick bites.

Conclusions

Our study showed the long‐term safety and efficacy of alpha‐gal OIT. Additionally, alpha‐gal sIgE seems to be a potential biomarker to monitor OIT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tick BitesFood HypersensitivityRed MeatAdultCattleHumansAnimalsSheepGalactoseAllergensBiomarkersImmunotherapyImmunoglobulin EMeat

Stichwörter der Autor:innen

alpha-gal allergydelayed-onsetearly-onsetlong-term efficacyoral immunotherapy

Substanzen

GalactoseAllergensBiomarkersImmunoglobulin E

Autor:innen und Institutionen

  • Division of Immunology and Allergy Diseases, Internal Medicine Department, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Medical Park Hospital Ordu, Ordu, Turkey.
  • Division of Immunology and Allergy Diseases, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey.

ORCID-Profile: D Ünal, D Eyice-Karabacak, S Demir, A Gelincik

Zitieren

APA

Ünal, D., Eyice-Karabacak, D., Kutlu, A., Demir, S., Tüzer, C., Arslan, A. F., Işık, S. R., & Gelincik, A. (2023). Oral immunotherapy in alpha‐gal red meat allergy: Could specific IgE be a potential biomarker in monitoring management?. Allergy, 78(12), 3241-3251. https://doi.org/10.1111/all.15840

Vancouver

Ünal D, Eyice-Karabacak D, Kutlu A, Demir S, Tüzer C, Arslan AF, et al. Oral immunotherapy in alpha‐gal red meat allergy: Could specific IgE be a potential biomarker in monitoring management?. Allergy. 2023;78(12):3241-3251. doi:10.1111/all.15840

BibTeX
@article{nal2023,
  author = {Ünal, D and Eyice-Karabacak, D and Kutlu, A and Demir, S and Tüzer, C and Arslan, A F and Işık, S R and Gelincik, A},
  title = {Oral immunotherapy in alpha‐gal red meat allergy: Could specific IgE be a potential biomarker in monitoring management?},
  journal = {Allergy},
  year = {2023},
  volume = {78},
  number = {12},
  pages = {3241--3251},
  doi = {10.1111/all.15840}
}
Kostenlos starten →